The Precision Prostatectomy: an IDEAL Stage 0, 1 and 2a Study
Anil K. Sood(The University of Texas MD Anderson Cancer Center), Mani Menon(Henry Ford Hospital), Firas Abdollah(Henry Ford Health System), Sohrab Arora(Leeds General Infirmary), Isaac Palma‐Zamora, Wooju Jeong(Henry Ford Hospital), Nilesh Gupta(Henry Ford Health System), Kanika Taneja(Henry Ford Health System)
Cited by 20
Related Papers
Monitoring dopants by Raman scattering in an electrochemically top-gated graphene transistor
|Nature Nanotechnology|2008|3.6k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Paraneoplastic Thrombocytosis in Ovarian Cancer
|New England Journal of Medicine|2012|822
Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer
|New England Journal of Medicine|2008|719